Giancarlo Comi, Robert Bermel, Amit Bar-Or, Marisa McGinley, Douglas Arnold, Roland Henry, Ralph Benedict, Pavan Bhargava, Helmut Butzkueven, Declan Chard, Guy Gherardi, Owain Howell, Christine Lebrun-Frenay, Letizia Leocani, Agne Kazlauskaite, Thomas Kuenzel, Xavier Montalban, Maria Pia Sormani, Finn Sellebjerg, Licinio Craveiro, Catherine Lubetzki. A multicentre, open label, single-arm, phase 3b study (CONSONANCE) to assess the effectiveness and safety of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year-1 interim analysis (P1-1.Virtual). Neurology. 2022 May 3; 98(18_supplement).